Den Boer et al stratified children with acute lymphoblastic leukemia (ALL) based on the in vitro resistance to prednisolone, vincristine and asparaginase. This can identify patients who may benefit from more aggressive management. The authors are from the Dutch Childhood Leukemia Study Group and the German Cooperative Study Group for Childhood Acute Lymphoblastic Leukemia (COALL).